The Effect of Time to Castration Resistance on Overall Survival and Success of Docetaxel Treatment in Castration Resistant Prostate Cancer Patients.

SÜER E., Hamidi N., Akpinar Ç., GÖKCE M. İ., GÜLPINAR Ö., Turkolmez K., ...More

Urology journal, vol.16, no.5, pp.453-457, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.22037/uj.v0i0.4497
  • Journal Name: Urology journal
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.453-457
  • Keywords: castration, chemotherapy, docetaxel, prostate cancer, survival, ABIRATERONE ACETATE, DOUBLE-BLIND, MITOXANTRONE, CABAZITAXEL, PREDNISONE, THERAPY, MEN
  • Ankara University Affiliated: Yes

Abstract

Purpose: To investigate the prognostic role of time to castration resistance(TTCR) in patients who have received solely Docetaxel chemotherapy regimen(DCR) for castration resistant prostate cancer(CRPC).